Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Scientific Reports|June 13, 2018
Diverse antimalarials from whole-cell phenotypic screens disrupt malaria parasite ion and volume homeostasisAdelaide S M Dennis, James E O Rosling, Adele M Lehane, et al.
Jac-Antimicrobial Resistance|October 10, 2024
Multidrug-resistant organism bloodstream infections in solid organ transplant recipients and impact on mortality: a systematic reviewAlice J Liu, Adelaide S M Dennis, Zarin Fariha, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2018
Cell Swelling Induced by the Antimalarial KAE609 (Cipargamin) and Other PfATP4-Associated AntimalarialsAdelaide S M Dennis, Adele M Lehane, Melanie C Ridgway, et al.
Heart, Lung & Circulation|March 9, 2024
Palliative Care Utilisation and Outcomes in Patients Admitted for Heart Failure in a Victorian Healthcare ServiceSylvia Ye, Cathy Corbett, Adelaide S M Dennis, et al.
Plos Pathogens|February 9, 2017
The Malaria Parasite's Lactate Transporter PfFNT Is the Target of Antiplasmodial Compounds Identified in Whole Cell Phenotypic ScreensSanduni V Hapuarachchi, Simon A Cobbold, Sarah H Shafik, et al.
Cell Chemical Biology|July 24, 2018
Defense Peptides Engineered from Human Platelet Factor 4 Kill Plasmodium by Selective Membrane DisruptionNicole Lawrence, Adelaide S M Dennis, Adele M Lehane, et al.
The Journal of Biological Chemistry|February 7, 2019
Characterization of the ATP4 ion pump in <i>Toxoplasma gondii</i>Adele M Lehane, Adelaide S M Dennis, Katherine O Bray, et al.
Nature Communications|September 30, 2022
A G358S mutation in the Plasmodium falciparum Na<sup>+</sup> pump PfATP4 confers clinically-relevant resistance to cipargaminDeyun Qiu, Jinxin V Pei, James E O Rosling, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2014
(+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of PlasmodiumMaría Belén Jiménez-Díaz, Daniel Ebert, Yandira Salinas, et al.
ACS Central Science|November 2, 2016
Open Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos ArylpyrrolesAlice E Williamson, Paul M Ylioja, Murray N Robertson, et al.
Pageof 1